Collectively, reduction of adipocyte-derived SPARC confers CR-like metabolic and antiinflammatory benefits in obesity by serving as an immunometabolic checkpoint of inflammation. Here, SPARC is linked to obesity due to melanocortin 4 receptor deficiency.